AzTrials
AzTrials

Duodenal DiverticulizationTRAUMADUODNCT06058975

National Retrospective Study of Duodenal Trauma

An observational study of Duodenal Diverticulization and Pyloric Exclusion, run by Centre Hospitalier Universitaire de Nice at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Duodenal injuries remain rare among abdominal trauma, concerning less than 5 % of cases. However, due to its central location, it is most commonly associated with multiple organs lesions, with the main three organs being the liver, the colon and the pancreas. Read more about this study

Who is it for?
Ages 18 to 100 years
What is being tested?
Observational
How many people
135 participants
Where
1 siteFrance
Study dates
8 Jan 2023to 31 Dec 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 100 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patient with duodenal trauma

Who may be able to join

  • patients with duodenal trauma,
  • older than 18 years old.

Who cannot join

  • pregnancy
  • previous duodenal surgery.
  • Associated surrounding organs trauma, was not an exclusion criterion, but duodenal trauma must have been one of the main injuries.

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU de Nice

    Nice, Alpes Maritimes, 06000

Other trials in France

About this study

Duodenal injuries remain rare among abdominal trauma, concerning less than 5 % of cases. However, due to its central location, it is most commonly associated with multiple organs lesions, with the main three organs being the liver, the colon and the pancreas. Additionally, the penetrating mechanism is four times more common than blunt trauma and the most common duodenal site of injury is the second portion (36 %), the least being the first duodenum (13 %). These particularities generate a high morbidity, ranging from 22 to 27.1 %, and a mortality still as high as 5.3 to 30 % today. When facing it, surgeons are usually challenged in their strategy. Indeed, when surgery is required, different options can be chosen depending on the grade of the lesion and the involvement of the papilla and/or other organs. Primary repairs, duodenal diverticulization, pyloric exclusion, gastrojejunostomy, retrograde duodenostomy, distal feeding tube, or even resection and Whipple procedures, have all been described. Since the classification of the American Association for the surgery of trauma (AAST), most studies stratified their management as such: drainage only or primary repair for grade 1 and 2, jejunostomy and/or pyloric exclusion for grade 3, Whipple for grade 4 or 5. However, reviews of the literature aren't clear if this decisional tree is in correlation with lower morbidities, and often different procedures have been reported for the same grade. The escalation of technical exclusions among severe grades became controversial. As an example, pyloric exclusion has been criticized in its preventive role of protecting the suture, being useless at least, or even worse at times. Thus, in the recent years, the management has been focused towards minimization. Indeed, in the retrospective review of the Pan-American trauma society primary repair alone was performed in 80 % of cases, all grades comprised. Although mortality was high, duodenal suture line leak was statistically lower among survivors over every grade.

To clear the situation, prospective studies are difficult if not impossible in such context. Thus, The investigators propose this national benchmark, to retrospectively review in France the management of duodenal trauma, depending on the grade, and its associated morbidity.

Being tested
Observational

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ObservationalOther

    Review the management of duodenal trauma in France

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Overall mortality

    Study mortality is overall mortality, not specific to abdominal trauma. It corresponds to grade 5 of the Clavien-Dindo classification.

    Measured: 1 month after trauma

  2. Specific mortality

    Specific mortality is the mortality due to abdominal trauma, including abdominal compartment syndrome, coagulopathy, hemorrhage, multi-organ failure, etc. It excludes brain death, mortality due to trauma of other body regions. It corresponds to grade 5 of the Clavien-Dindo classification.

    Measured: 1 month after trauma

Secondary outcomes (3)
  1. Severe morbidity

    Morbidity will be recorded according to the Clavien-Dindo classification. We will study overall morbidity and severe morbidity (stages 3 and 4). As a reminder, stage 1 corresponds to a simple deviation from the operative course, stage 2 to medical treatment, stage 3 to interventional management (with or without general anaesthesia), and stage 4 to organ or multi-visceral failure.

    Measured: 3 months after trauma

  2. Kind of treatment: medical, endoscopic or surgical

    We will record the type of initial treatment performed, whether non-operative, endoscopic, laparoscopic or by laparotomy.

    We will collect the results of this initial treatment, including the possibility of complementary treatments, whatever the approach used and any failures.

    Non-operative management is defined as an exclusive medical attitude, including diagnostic imaging, but without interventional procedures.

    Interventional radiology management is defined as a percutaneous procedure performed under the control of diagnostic imaging, e.g. ultrasound- or scan-guided puncture of a collection.

    Endoscopic management includes diagnostic or therapeutic endoscopy, for example: endoscopic realignment of the Wirsung duct, puncture of a pancreatic pseudocyst, duodenal stenting, etc.

    Surgical management is defined as any surgical procedure requiring an opening of the abdomen. The approach is indicated as laparotomy or laparoscopy.

    Measured: The first 3 months after trauma

  3. type of injury of the duodenum

    The surgeon is free to describe the lesions, in order to gather as much information as possible on the location of the lesion, its size, etc.

    We will also ask investigators to describe the lesions encountered, using the classification established by the AAST (American Association for the Surgery of Trauma).

    Measured: no later than the 7th day after the trauma

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Sep 2023
  2. Study start8 Jan 2023
  3. Primary completion30 Sep 2023
  4. Study completion31 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
135 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06058975
Sponsor's protocol ID
23Urgences02
Acronym
TRAUMADUOD
Status last verified
Sep 2023
First submitted
30 Aug 2023
Last updated
2 Apr 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Frey S, Bentellis I, Gaujoux S, Girard E, Abba J, Chirica M, Bertrand M, Boutry E, Mege D, Aubert M, Alves A, Hornez E, Mulliri A, Brustia R, Hentati H, Lauka L, Laurent A, Sommacale D, Turco C, Dezeustre M, Bajul M, Castel A, Facy O, Grellet R, Sulpice L, Menegaux F, Delestre M, Lermite E, Monchal T, Amrou R, Bacoeur-Ouzillou O, Pezet D, Bonnet J, Buc E, Passot G, Schneck AS, Birnbaum DJ, Blanc PY, Le Roy B, Monneuse O, Rodriguez Q, Suc B, Baque P, Dubuisson V, Massalou D. How are duodenal trauma managed? A French nationwide study. World J Emerg Surg. 2025 Dec 9;20(1):89. doi: 10.1186/s13017-025-00661-z.

    PubMed 41366408

Questions about this trial

What is this clinical trial studying?

An observational study of Duodenal Diverticulization and Pyloric Exclusion, run by Centre Hospitalier Universitaire de Nice at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Overall mortality (time frame: 1 month after trauma). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06058975, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Apr 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in